Pierre Ronco

28.9k total citations · 3 hit papers
349 papers, 15.1k citations indexed

About

Pierre Ronco is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pierre Ronco has authored 349 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Nephrology, 118 papers in Molecular Biology and 81 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pierre Ronco's work include Renal Diseases and Glomerulopathies (157 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (50 papers) and Vasculitis and related conditions (43 papers). Pierre Ronco is often cited by papers focused on Renal Diseases and Glomerulopathies (157 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (50 papers) and Vasculitis and related conditions (43 papers). Pierre Ronco collaborates with scholars based in France, United States and United Kingdom. Pierre Ronco's co-authors include Hanna Dêbiec, B. Mougenot, P Verroust, Emmanuelle Plaisier, Brigitte Lelongt, Pièrre Aucouturier, Karine Dahan, Philippe Moreau, François Châtelet and Sanjeev Sethi and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Pierre Ronco

342 papers receiving 14.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

2005 992 citations Pierre Ronco et al. profile →
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

2016 281 citations Karine Dahan, Hanna Dêbiec et al. Journal of the American Society of Nephrology profile →
Membranous nephropathy

2021 248 citations Pierre Ronco, Hanna Dêbiec et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre Ronco France	69	7.7k	5.5k	3.4k	2.7k	1.9k	349	15.1k
Patrick Niaudet France	61	6.5k 0.8×	4.6k 0.8×	2.2k 0.7×	1.9k 0.7×	1.5k 0.8×	295	13.4k
Helmut G. Rennke United States	63	7.8k 1.0×	4.2k 0.8×	2.6k 0.8×	1.1k 0.4×	925 0.5×	196	16.8k
Mark Haas United States	71	6.7k 0.9×	3.8k 0.7×	2.6k 0.8×	1.1k 0.4×	1.0k 0.5×	238	16.5k
Wayne A. Border United States	58	5.4k 0.7×	6.7k 1.2×	2.1k 0.6×	957 0.4×	953 0.5×	118	17.0k
Benjamin D. Humphreys United States	71	4.9k 0.6×	8.6k 1.6×	2.9k 0.9×	1.2k 0.5×	545 0.3×	184	16.9k
Stuart J. Shankland United States	70	8.4k 1.1×	6.8k 1.2×	1.5k 0.4×	1.1k 0.4×	510 0.3×	229	15.2k
Moin A. Saleem United Kingdom	67	7.8k 1.0×	5.8k 1.1×	1.1k 0.3×	1.4k 0.5×	553 0.3×	324	14.4k
Roel Goldschmeding Netherlands	65	2.3k 0.3×	5.4k 1.0×	2.6k 0.8×	1.2k 0.5×	683 0.4×	259	12.3k
Jochen Reiser United States	51	9.1k 1.2×	5.3k 1.0×	944 0.3×	1.5k 0.6×	590 0.3×	179	14.1k
Kazumoto Iijima Japan	45	4.0k 0.5×	3.2k 0.6×	1.3k 0.4×	1.4k 0.5×	1.1k 0.6×	499	9.0k

Countries citing papers authored by Pierre Ronco

Since Specialization

Citations

This map shows the geographic impact of Pierre Ronco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Ronco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Ronco more than expected).

Fields of papers citing papers by Pierre Ronco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Ronco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Ronco. The network helps show where Pierre Ronco may publish in the future.

Co-authorship network of co-authors of Pierre Ronco

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Ronco. A scholar is included among the top collaborators of Pierre Ronco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Ronco. Pierre Ronco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berge, Bartholomeus T. van den, Martijn van den Broek, Hanna Dêbiec, et al.. (2025). Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome. Nephrology Dialysis Transplantation. 40(9). 1736–1745.

Dolla, Guillaume, Sarah Nicolas, Alexandre Bourgeois, et al.. (2024). Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17. Journal of Biological Chemistry. 300(7). 107480–107480. 5 indexed citations

Eikrem, Øystein, Nicolas Delaleu, Tarig Osman, et al.. (2023). Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target. Biomedicines. 11(1). 226–226. 4 indexed citations

Torreggiani, Massimo, Antioco Fois, Antoine Chatrenet, et al.. (2022). Incremental and Personalized Hemodialysis Start: A New Standard of Care. Kidney International Reports. 7(5). 1049–1061. 21 indexed citations

Zhang, Xiaodan, Zhao Cui, Lei Liu, et al.. (2022). Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy. Kidney International. 103(3). 580–592. 8 indexed citations

Rovin, Brad H., Sharon G. Adler, Elion Hoxha, et al.. (2021). Felzartamab in Patients with Anti-Phospholipase A2 Receptor Autoantibody Positive (Anti-PLA2R+) Membranous Nephropathy (MN): Interim Results from the M-PLACE Study. Journal of the American Society of Nephrology. 32(10S). 513–514. 1 indexed citations

Sethi, Sanjeev, Benjamin J. Madden, Hanna Dêbiec, et al.. (2021). Protocadherin 7–Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 32(5). 1249–1261. 98 indexed citations

Usui, Joichi, Satoshi Yamazaki, Shuzo Kaneko, et al.. (2020). Transcription factor 21 expression in injured podocytes of glomerular diseases. Scientific Reports. 10(1). 11516–11516. 6 indexed citations

Plaisier, Emmanuelle & Pierre Ronco. (2020). Screening for Cancer in Patients with Glomerular Diseases. Clinical Journal of the American Society of Nephrology. 15(6). 886–888. 29 indexed citations

10.

Sethi, Sanjeev, Benjamin J. Madden, Vivian Negron, et al.. (2020). Protocadherin 7-Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 31(10S). 26–26. 3 indexed citations

11.

Sethi, Sanjeev, Benjamin Madden, Hanna Dêbiec, et al.. (2019). Exostosin 1/Exostosin 2–Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 30(6). 1123–1136. 196 indexed citations

12.

Fessi, Hafedh, et al.. (2018). Conservative three-quarter versus subtotal seven-eighths parathyroidectomy in secondary hyperparathyroidism. European Annals of Otorhinolaryngology Head and Neck Diseases. 136(2). 63–68. 3 indexed citations

13.

Estève, Emmanuel, Dominique Bazin, Chantal Jouanneau, et al.. (2016). How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs?: An investigation combining μXRF and statistical analysis. Part II: Clinical application. Comptes Rendus Chimie. 19(11-12). 1586–1589. 13 indexed citations

14.

Michel, P.A., Karine Dahan, Pierre‐Yves Ancel, et al.. (2011). Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients. PubMed. 1(1). 251–261. 19 indexed citations

15.

Maigné, G., Sophie Ferlicot, Frederic Galactéros, et al.. (2010). Glomerular Lesions in Patients With Sickle Cell Disease. Medicine. 89(1). 18–27. 48 indexed citations

16.

Bollée, Guillaume, F. Martinez, Bruno Moulin, et al.. (2010). Renal biopsy practice in France: results of a nationwide study. Nephrology Dialysis Transplantation. 25(11). 3579–3585. 29 indexed citations

17.

Favrè, Guillaume, P Callard, Magali Colombat, et al.. (2009). Membranoproliferative Glomerulonephritis, Chronic Lymphocytic Leukemia, and Cryoglobulinemia. American Journal of Kidney Diseases. 55(2). 391–394. 11 indexed citations

18.

Jouanneau, Chantal, Sophie Vandermeersch, Gerry Melino, et al.. (2008). Tissue Transglutaminase Contributes to Interstitial Renal Fibrosis by Favoring Accumulation of Fibrillar Collagen through TGF-β Activation and Cell Infiltration. American Journal Of Pathology. 173(3). 631–642. 124 indexed citations

19.

Plaisier, Emmanuelle, David Ribes, Pierre Ronco, & Jérôme Rossert. (2005). Identification of two candidate collecting duct cell-specific cis-acting elements in the Hoxb-7 promoter region. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1727(2). 106–115. 3 indexed citations

20.

Vandewalle, Alain, M.E. Rafestin-Oblin, Jacqueline Hagège, et al.. (1993). Phenotypic effects of aldosterone and dexamethasone in a SV40‐transformed mammalian cortical ascending limb cell line exhibiting mineralocorticoid receptors. Journal of Cellular Physiology. 156(2). 383–394. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact